COPD at the Time of COVID-19: A COPD Foundation Perspective.
作者信息
Tal-Singer Ruth, Crapo James D
机构信息
COPD Foundation, Washington, D.C.
Editor in Chief, Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, COPD Foundation, Washington, DC.
出版信息
Chronic Obstr Pulm Dis. 2020 Apr;7(2):73-75. doi: 10.15326/jcopdf.7.2.2020.0149.
Abstract
摘要
相似文献
1
COPD at the Time of COVID-19: A COPD Foundation Perspective.COVID-19时期的慢性阻塞性肺疾病：慢性阻塞性肺疾病基金会观点
Chronic Obstr Pulm Dis. 2020 Apr;7(2):73-75. doi: 10.15326/jcopdf.7.2.2020.0149.
2
Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019.哮喘、慢性阻塞性肺疾病（COPD）及哮喘-COPD重叠综合征对2019冠状病毒病预后的影响
Asia Pac Allergy. 2022 Apr 28;12(2):e21. doi: 10.5415/apallergy.2022.12.e21. eCollection 2022 Apr.
3
Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).慢性阻塞性肺疾病（COPD）、肺动脉高压（PAH）和 2019 年冠状病毒病（COVID-19）之间生化过程的相互作用。
Pol J Microbiol. 2023 Jun 14;72(2):143-154. doi: 10.33073/pjm-2023-015. eCollection 2023 Jun 1.
4
[Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].[2019冠状病毒病流行期间慢性阻塞性肺疾病的医疗管理与预防指导]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 May 12;43(5):421-426. doi: 10.3760/cma.j.cn112147-20200227-00201.
5
Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease.新冠病毒肺炎（COVID-19）的死亡率与慢性阻塞性肺疾病患者的合并症有关。
Infect Dis (Lond). 2022 Jul;54(7):508-513. doi: 10.1080/23744235.2022.2050422. Epub 2022 Mar 14.
6
Asthma Patients Benefit More Than Chronic Obstructive Pulmonary Disease Patients in the Coronavirus Disease 2019 Pandemic.在2019冠状病毒病大流行中，哮喘患者比慢性阻塞性肺疾病患者受益更多。
Front Med (Lausanne). 2021 Sep 10;8:709006. doi: 10.3389/fmed.2021.709006. eCollection 2021.
7
Evaluation of the Effect of COVID-19 Vaccination on Exacerbations of Chronic Obstructive Pulmonary Disease: A Single-Center Study.2019冠状病毒病疫苗接种对慢性阻塞性肺疾病急性加重影响的评估：一项单中心研究
Cureus. 2022 Dec 20;14(12):e32751. doi: 10.7759/cureus.32751. eCollection 2022 Dec.
8
Impact of Chronic Obstructive Pulmonary Disease and Emphysema on Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Pneumonia.慢性阻塞性肺疾病和肺气肿对2019冠状病毒病肺炎住院患者预后的影响。
Chronic Obstr Pulm Dis. 2021 Apr 27;8(2):255-268. doi: 10.15326/jcopdf.2020.0200.
9
Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization.慢性阻塞性肺疾病患者出院后对冠状病毒 2019 住院的医疗利用。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 22;18:1827-1835. doi: 10.2147/COPD.S415621. eCollection 2023.
10
Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China.中国湖北省 COVID-19 流行期间慢性阻塞性肺疾病患者的临床病程和结局。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 23;15:2237-2248. doi: 10.2147/COPD.S265004. eCollection 2020.
引用本文的文献
1
Validation of the Test of Adherence to Inhalers (TAI) among Taiwanese Patients with Chronic Obstructive Pulmonary Disease.台湾慢性阻塞性肺疾病患者吸入器使用依从性测试（TAI）的验证
Med Sci Monit. 2025 Jun 13;31:e948762. doi: 10.12659/MSM.948762.
2
Role of Biomarkers Diagnostic Tools in Patients with COVID-19: Stratification Made Easy.生物标志物诊断工具在新冠肺炎患者中的作用：分层变得简单。
Int J Gen Med. 2024 Oct 25;17:4895-4906. doi: 10.2147/IJGM.S488968. eCollection 2024.
3
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study.评估长期吸入性糖皮质激素治疗对新冠肺炎合并慢性肺部疾病患者的影响：一项多中心回顾性队列研究。
Can J Respir Ther. 2024 Jun 5;60:86-94. doi: 10.29390/001c.118514. eCollection 2024.
4
Features and characteristics of publicly available mHealth apps for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的公开可用移动健康应用程序的特点与特性。
Digit Health. 2023 Apr 12;9:20552076231167007. doi: 10.1177/20552076231167007. eCollection 2023 Jan-Dec.
5
Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data.抗抑郁药对新冠病毒病结局的影响：基于大规模电子健康记录数据的回顾性研究
Interact J Med Res. 2023 Apr 11;12:e39455. doi: 10.2196/39455.
6
COVID-19 effect on patients with noncommunicable diseases: A narrative review.2019冠状病毒病对非传染性疾病患者的影响：一项叙述性综述。
Health Sci Rep. 2022 Dec 15;6(1):e995. doi: 10.1002/hsr2.995. eCollection 2023 Jan.
7
Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.靶向新冠病毒感染中的炎性小体激活：基于RNA干扰的治疗性分子递送
Biomedicines. 2021 Dec 3;9(12):1823. doi: 10.3390/biomedicines9121823.
8
Physical and Mental Health Impacts of the COVID-19 Pandemic among US Adults with Chronic Respiratory Conditions.新冠疫情对美国患有慢性呼吸道疾病成年人身心健康的影响
J Clin Med. 2021 Sep 2;10(17):3981. doi: 10.3390/jcm10173981.
9
Computed tomography findings of COVID-19 pneumonia in Intensive Care Unit-patients.重症监护病房中新冠肺炎患者的计算机断层扫描结果
J Public Health Res. 2021 Apr 19;10(3):2270. doi: 10.4081/jphr.2021.2270.
10
Development of Respercise® a Digital Application for Standardizing Home Exercise in COPD Clinical Trials.Respercise®的开发——一种用于慢性阻塞性肺疾病临床试验中家庭锻炼标准化的数字应用程序。
Chronic Obstr Pulm Dis. 2021 Apr 27;8(2):269-276. doi: 10.15326/jcopdf.2020.0194.
本文引用的文献
1
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.COPD 和吸烟史对 COVID-19 严重程度的影响：系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
2
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).吸烟上调血管紧张素转换酶2受体：新型冠状病毒SARS-CoV-2（新冠病毒）的潜在粘附位点。
J Clin Med. 2020 Mar 20;9(3):841. doi: 10.3390/jcm9030841.
3
What to Do When Pulmonary Rehabilitation (PR) Is Unavailable.当无法进行肺康复治疗（PR）时该怎么办。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):P25-P26. doi: 10.1164/rccm.2020C4.
4
Diagnosis and Management of COVID-19 Disease.新型冠状病毒肺炎的诊断与管理
Am J Respir Crit Care Med. 2020 May 15;201(10):P19-P20. doi: 10.1164/rccm.2020C1.
5
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
6
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).主动吸烟与2019冠状病毒病（COVID-19）的严重程度无关。
Eur J Intern Med. 2020 May;75:107-108. doi: 10.1016/j.ejim.2020.03.014. Epub 2020 Mar 16.
7
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
8
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.分析与 2019 年新型冠状病毒病住院患者疾病结局相关的因素。
Chin Med J (Engl). 2020 May 5;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.
9
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
10
Nicotine and the renin-angiotensin system.尼古丁与肾素-血管紧张素系统。
Am J Physiol Regul Integr Comp Physiol. 2018 Nov 1;315(5):R895-R906. doi: 10.1152/ajpregu.00099.2018. Epub 2018 Aug 8.
Zotero 插件